Hypoxic postconditioning attenuates apoptosis via inactivation of adenosine A2a receptor through NDRG3-Raf-ERK

Chao Cui1, Huang Lin1, Yanyu Shi1

  • 1Department of Aesthetic Plastic Surgery and Laser Medicine, Beijing Anzhen Hospital, Capital Medical University, Anzhen Road #2, Chaoyang District, Beijing 100029, China.

Abstract

Insights

Hypoxia postconditioning protects human dermal microvascular endothelial cells from injury by reducing apoptosis. This protective effect involves the adenosine A2a receptor and the NDRG3-Raf-ERK pathway, highlighting potential therapeutic targets for flap preservation.

Area of Science:

  • Cell Biology
  • Physiology
  • Biochemistry

Background:

  • Endogenous adenosine from ischemia postconditioning reduces apoptosis in various models.
  • The effects of hypoxia postconditioning (HPC) on human dermal microvascular endothelial cells (HDMECs) and the specific adenosine receptors involved remain unclear.

Purpose of the Study:

  • To investigate the roles of adenosine A2a receptor, NDRG3, and the Raf-ERK pathway in the anti-apoptotic effects of HPC in HDMECs.
  • To elucidate the mechanisms underlying HPC-mediated protection against apoptosis in HDMECs.

Main Methods:

  • HDMECs were subjected to hypoxia/reoxygenation (H/R) and subsequently treated with HPC.
  • Mitochondrial function (pore opening, membrane potential) and protein expression (apoptosis markers, adenosine A2a receptor, NDRG3-Raf-ERK pathway) were assessed using kits and western blot.

Main Results:

  • H/R induced HDMEC injury, increasing apoptosis and pro-apoptotic protein expression while decreasing anti-apoptotic Bcl-2.
  • HPC significantly attenuated H/R-induced injury and apoptosis.
  • HPC treatment upregulated adenosine A2a receptor, NDRG3, p-c-Raf, and p-ERK.
  • The protective effect of HPC was diminished by the adenosine A2a receptor agonist CGS21680.

Conclusions:

  • Hypoxia postconditioning exerts a protective effect against H/R-induced apoptosis in HDMECs.
  • The adenosine A2a receptor and the NDRG3-Raf-ERK pathway are crucial mediators of HPC's anti-apoptotic effects.
  • Targeting the adenosine A2a receptor may offer a therapeutic strategy for improving flap survival.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.0K